Download FREE Report Sample
Download Free sampleNon-alcoholic Steatohepatitis Biomarkers Market contains market size and forecasts of Non-alcoholic Steatohepatitis (NASH) Biomarkers in global, including the following market information:
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Non-alcoholic Steatohepatitis (NASH) Biomarkers companies in 2021 (%)
The global Non-alcoholic Steatohepatitis (NASH) Biomarkers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Serum Biomarkers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers include Biopredictive, Quest Diagnostics, Exalenz Bioscience, GENFIT, Siemens Healthineers, ONE WAY LIVER, Prometheus Laboratories and Gilead Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-alcoholic Steatohepatitis (NASH) Biomarkers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Segment Percentages, by Type, 2021 (%)
Serum Biomarkers
Cytokeratin-18 (CK 18) Marker
Inflammatory Markers
Others
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostic Centers
Others
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-alcoholic Steatohepatitis (NASH) Biomarkers revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Non-alcoholic Steatohepatitis (NASH) Biomarkers revenues share in global market, 2021 (%)
Key companies Non-alcoholic Steatohepatitis (NASH) Biomarkers sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Non-alcoholic Steatohepatitis (NASH) Biomarkers sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biopredictive
Quest Diagnostics
Exalenz Bioscience
GENFIT
Siemens Healthineers
ONE WAY LIVER
Prometheus Laboratories
Gilead Sciences
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy